Log in or Sign up for Free to view tailored content for your specialty!
Cutaneous Oncology News
Age-related skin changes may contribute to melanoma metastases among older adults
Age-related changes to the skin’s elasticity may drive higher rates of metastatic skin cancer among older individuals, according to study results.
No cardiac effects from topical hypericin in patients with mycosis fungoides
Topical hypericin showed efficacy in treating mycosis fungoides without significant skin absorption or significant cardiac changes, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
Nasal tip rotation flaps successfully repair nasal defects from Mohs surgery
Nasal tip rotation flaps are reliable solutions for repairing defects on the distal nose following Mohs micrographic surgery, according to a study.
Recessive dystrophic epidermolysis bullosa subtypes linked to type VII protein function
Based on a variant’s impact on type VII collagen protein function, patients with recessive dystrophic epidermolysis bullosa can be categorized into clinically meaningful subgroups to better guide disease management, according to a study.
‘Anxiety about aging’: How dermatologists can discuss sun safety with Gen Z adults
Generation Z adults love skin care but are less enthusiastic about sunscreen and sun safety practices, putting them at a higher risk for skin cancer, according to a new survey from the American Academy of Dermatology.
Age, anatomical location-related factors dictate biopsy considerations for T1b melanomas
Younger patients and those with T1b melanomas on the face, ear or scalp should undergo sentinel lymph node biopsies, according to a study.
Quality of life measures improve with topical tirbanibulin for actinic keratosis
Actinic keratosis lesions were reduced and quality of life improved following once-daily topical tirbanibulin treatment, according to a study.
Mohs surgery techniques may cause hyperpigmentation among patients with skin of color
Procedural factors influence post-inflammatory hyperpigmentation following Mohs micrographic surgery among patients with skin of color, according to a study.
Vibostolimab, pembrolizumab coformulation trial discontinued for resected high-risk melanoma
Merck has discontinued the vibostolimab and pembrolizumab coformulation arm of its phase 3 trial for the adjuvant treatment of patients with resected high-risk melanoma, the company announced in a press release.
Not all treatments created equal: Identifying barriers to immunotherapy for melanoma
Immunotherapy is a life-saving treatment for melanoma, but not all individuals have access to this treatment, according to a study.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read